Reid C. Thompson

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Florence M.G. Cavalli, Marc Remke, Ladislav Rampášek et al. · Cancer Cell · 2017 · 1.3K citations · Full text

Medicine, Genetics, Oncology +14

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Paul A. Northcott, David Shih, John Peacock et al. · Nature · 2012 · 921 citations · Full text

Medicine, Genetics, Oncology +17

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

William P. Arend, Howard G. Welgus, Reid C. Thompson et al. · Journal of Clinical Investigation · 1990 · 592 citations · Full text

Life Sciences, Cell Biology, Immunology +9

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Linda M. Liau, Keyoumars Ashkan, David D. Tran et al. · Journal of Translational Medicine · 2018 · 540 citations · Full text

Medicine, Immunology, Oncology +17